Outcomes in patients with BRAF V600 -mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib.

Massimo AgliettaVanna Chiarion-SileniPaolo FavaMassimo GuidoboniRoberta DepenniAlessandro MinisiniFrancesca ConsoliPaolo Antonio AsciertoGaetana RinaldiMaria BanziRiccardo MarconciniRossana GueliVirginia FerraresiMarco TucciGiuseppe ToniniGiovanni Lo ReMichele GuidaMichele Del VecchioIlaria Gioia MarconPaola Queirolo

Published in: Tumori (2023)

-mutated melanoma and BM at baseline, supporting its use in this population with poor outcomes.

Keyphrases

brain metastases
small cell lung cancer
wild type
skin cancer
type diabetes
metabolic syndrome
insulin resistance
newly diagnosed